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Alpha/Beta and Gamma Interferons Are Induced by Infection
with Noncytopathic Bovine Viral Diarrhea Virus In Vivo
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In contrast to the results of previous in vitro studies, experimental infection of calves with noncytopathic
bovine viral diarrhea virus (ncpBVDV) was found to induce strong alpha/beta and gamma interferon responses
in gnotobiotic animals. These responses were associated with depressed levels of transforming growth factor
 (TGF-) in serum. The results of this study indicate that the immunosuppression caused by ncpBVDV is not
associated with low interferon responses or elevated levels of TGF-.
Bovine viral diarrhea virus (BVDV) is a positive-sense single-
stranded RNA virus belonging to the genus Pestivirus. Two
biotypes of the virus, cytopathic and noncytopathic, are iden-
tifiable based on their lytic activities in in vitro cultures. The
high prevalence of cattle herds infected with BVDV in many
countries throughout the world is believed to be a consequence
of the ability of noncytopathic BVDV (ncpBVDV) to establish
lifelong infections after in utero infection in early pregnancy
and thus to generate a reservoir of persistently infected ani-
mals. Although acute infections with ncpBVDV are often
asymptomatic or produce only mild clinical symptoms, there is
evidence that they result in immunosuppression. This suppo-
sition is based on experimental studies in which acute infection
of calves with BVDV was found to enhance susceptibility to
infection with bovine herpesvirus 1 as well as on field obser-
vations indicating increased susceptibility to intercurrent infec-
tions after acute infection with BVDV. The mechanism of
immunosuppression induced by BVDV has not been deter-
mined, although there has been considerable speculation,
based largely on in vitro observations (reviewed in reference
17). ncpBVDV isolates have been shown not to induce alpha/
beta interferon (IFN-/) in vitro (2, 8, 16) and to block the
induction of IFN by double-stranded RNA or by infection with
other viruses (19, 21).
Given the antiviral properties of IFN-/ and recent evi-
dence that it has a role in promoting Th1 T-cell responses (9),
inhibition of IFN-/ induction by ncpBVDV clearly has the
potential to alter immune responses and hence to contribute to
increased susceptibility to intercurrent infections. The princi-
pal aim of the present study was to determine whether or not
ncpBVDV induces IFN-/ responses in vivo. Gnotobiotic
calves (7) were used to provide animals with minimal back-
ground cytokine responses and to ensure that any production
of IFN was not due to the presence of bacterial endotoxins.
Feces samples from each calf were examined each week after
birth, and all samples were sterile. In contrast to the in vitro
findings with virus-infected cells, ncpBVDV was found to stim-
ulate potent IFN-/ responses in vivo.
Primary infection with ncpBVDV results in transient sup-
pression of responses to BCG. Seven gnotobiotic calves were
used in this study. Six of the calves were infected at 30 days of
age by intranasal inoculation with 5  106 PFU of ncpBVDV
11249, an isolate that has been used extensively in previous
experimental studies and that gives reproducible infection pro-
files (22). The remaining calf was mock infected with virus-free
cell culture supernatant instilled intranasally. In order to ex-
amine the effect of infection with ncpBVDV on T-cell re-
sponses to an unrelated antigen, two of the BVDV-infected
calves and the control calf had been vaccinated subcutaneously
with 106 CFU of the Pasteur strain of Mycobacterium bovis
bacillus Calmette-Gue´rin (BCG) 28 days prior to infection.
Viremia was detected as described previously (11) in the
BVDV-challenged animals on days 3, 5, and 7 postinfection
(p.i.) (Fig. 1) but not on day 14 or 21 p.i. or in any samples from
the mock-infected animal. The virus titers detected after acute
infection in this study were consistent with those found in
previous studies (11). Blood from these animals was monitored
for IFN- production and proliferative responses to purified
proteins derived from M. bovis (purified protein derivative B
[PPD-B]) as described previously (13) prior to and following
infection with BVDV. Cell proliferation and IFN- production
in the in vitro restimulation cultures are shown in Fig. 2.
At the time of challenge with BVDV, all three BCG-vacci-
nated calves exhibited strong proliferative responses to PPD-B.
Previous studies have shown that CD4 T cells make up a large
portion of the responding T cells in this assay (13). In the calf
that was not infected with BVDV, the response to PPD-B
continued to increase over the next three weeks. By contrast,
the response to PPD-B was almost completely eliminated in
the two BVDV-infected calves 7 days after infection. One calf
still exhibited complete suppression of the proliferative re-
sponse and the other exhibited partial suppression on day 14
after challenge. After 21 days, the proliferative response was
recovered in both calves challenged with BVDV. Duplicate
cultures were used to examine IFN- production. A similarly
profound suppression of the IFN- response to PPD-B was
observed following infection with BVDV, with almost com-
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plete suppression at 7 days in both animals and also at 14 days
in one of the animals.
To determine whether the presence of infectious virus in
the cultures had a direct effect on the proliferative response,
ncpBVDV was added at titers ranging from 10 to 104 PFU per
well to assays with blood collected on day 21 from the animal
vaccinated with BCG alone. The added virus had no effect on
the proliferative response to the antigen (data not shown),
indicating that the suppression of proliferation was not merely
due to the presence of virus in the assay.
Primary infection with ncpBVDV results in production of
IFN-/. IFN production in response to infection with BVDV
was assessed by measuring the levels of biologically active
IFN-/ in duplicate serum samples from the BVDV-infected
and mock-infected animals with an IFN-inducible Mx gene
promoter reporter assay as previously described (12). Mx pro-
tein has been used extensively as a sensitive indicator of IFN-
/ bioactivity (15).
As observed with other isolates of ncpBVDV, isolate 11249
failed to induce either IFN-/ or Mx protein (Fig. 3) in vitro
in a number of bovine cell types, including isolated blood
monocytes. By contrast, IFN was readily detected in sera from
FIG. 1. Mean viral titers in the sera of six gnotobiotic calves chal-
lenged intranasally with 5  106 PFU of ncpBVDV 11249. The bars
show the mean titers (PFU per milliliter)  standard errors of the
means (SEM).
FIG. 2. Cell proliferation (A) and IFN- production (B) in response to PPD-B in blood from gnotobiotic calves. Calves were infected with
either BVDV and BCG (i and ii) or BCG alone (iii). BVDV challenge was performed on day 0; BCG challenge had been performed 28 days
previously. Cell proliferation in each sample was analyzed in triplicate, and mean values  standard deviations (error bars) are shown. IFN-
production in each sample was analyzed in duplicate, and mean values are shown.
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infected animals; serum IFN was elevated from day 1 until day
7 p.i. (Fig. 4). These IFN responses in BVDV-infected calves
that had been vaccinated with BCG were similar to those in the
unvaccinated calves. IFN was not detected in the serum of the
mock-infected gnotobiotic animal or in those of five age-
matched conventional calves after mock infection (data not
shown).
The kinetics and quantity of IFN-/ induced following
BVDV challenge are consistent with those seen during acute
viral infections in other species (3) and indicate that IFN is
generated as part of the innate immune response to the virus.
The induction of IFN-/ in vivo by ncpBVDV contrasts with
in vitro observations (2, 8, 16) indicating that the virus is able
to inhibit endogenous induction of IFN-/ in virus-infected
cells.
Further studies are required to determine which cells pro-
duce IFN in vivo, to determine whether or not the IFN-pro-
ducing cells are infected with BVDV, and to explain the dis-
crepancy between the in vivo and in vitro findings for the
induction of IFN-/ by ncpBVDV.
ncpBVDV stimulates IFN- responses in vivo. In light of the
recent evidence that early IFN-/ production can promote
Th1 T-cell responses in humans (9), the animals were also
examined for evidence of IFN- production. IFN- in serum
was quantified using a commercially produced enzyme-linked
immunosorbent assay (Bovigam; CSL Limited, Parkville, Aus-
tralia). Gnotobiotic calves infected with ncpBVDV were found
to produce detectable levels of IFN- in serum. IFN- produc-
tion appeared to be biphasic, with the first peak occurring after
3 days (although the values on days 2, 3, 4, and 5 were not
significantly different [t test, P  0.05]) and with the second
peak occurring after 6 days (Fig. 5). IFN- was not detected in
the sera of the mock-infected animals. Based on observations
of viral infections in mice, it is likely that the first peak of
IFN- is produced by natural killer (NK) cells and that the
second peak is produced by activated T cells (3).
The quantity of circulating TGF- is reduced during acute
ncpBVDV infection. IFN- has been shown to inhibit the pro-
duction of latent transforming growth factor 1 (TGF-1) by
mouse inflammatory macrophages (20). Hence, we investi-
gated whether there are changes in the quantity of circulating
TGF- which correlate with the period of IFN- production.
Infection with ncpBVDV failed to induce either active or
latent TGF-1 protein (Quantikine human TGF-1 assay; R &
D Systems, Abingdon, United Kingdom) in the sera of gnoto-
biotic calves (Fig. 6). The concentrations of circulating latent
TGF-1 protein were consistent with values found in studies of
infection with Epstein-Barr virus in humans; however, the
quantity of circulating active TGF-1 protein was approxi-
mately 100-fold lower than that found in the same study (23)
and was probably not biologically significant. Also, there was
no significant difference among the quantities of active
TGF-1 in the sera of the infected calves at each time point
studied (t test, P  0.05). However, the quantities of active
TGF-1 in the sera of the infected calves were significantly
lower than that of the control animal on days 7 and 14 post-
challenge (t test, P  0.05). In conclusion, acute infection with
FIG. 3. Mx expression in bovine monocytes infected either with
mock antigen or with ncpBVDV 11249 or stimulated with poly(I-C) (1
	g/ml). Mx protein was detected only in monocytes treated with
poly(I-C).
FIG. 4. Kinetics of IFN-/ production in the sera of calves after intranasal challenge infection with 5  106 PFU of ncpBVDV isolate 11249
(}). Individual samples were analyzed in duplicate, and the mean values were determined. Titers are expressed as the means of values for six
animals  SEM. Titers for the mock-infected animal are shown separately ().
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ncpBVDV does not induce either latent or active TGF-1 in
the sera of gnotobiotic calves.
Relevance of findings to BVDV-associated immunosuppres-
sion. The findings of this study show that strong IFN-/ and
IFN- responses are induced in vivo after acute ncpBVDV
infection. Thus, despite the in vitro observation that ncpBVDV
is able to inhibit endogenous induction of IFN-/, infection
does not appear to result in impaired IFN responses in vivo
that might account for enhanced susceptibility to other viral
infections. There is also no evidence of increased production of
TGF-, which is known to suppress T-cell responses (10) and
has been implicated in immunosuppression associated with
equine herpesvirus 2 infections (5). Evidence that infection
with the isolate of ncpBVDV used in this study results in
immunosuppression was obtained by demonstrating a marked
suppression in T-cell proliferation and IFN- production in
response to PPD-B in calves previously vaccinated with BCG.
Somewhat surprisingly, the initial detection of IFN- suppres-
sion coincided with the period when high levels of IFN- were
detected in the sera of the BVDV-infected calves. Despite this
potent IFN- response, we have shown previously that T-cell
proliferative responses to ncpBVDV are not readily detected
during the first 4 to 5 weeks after infection with the virus (6).
These findings collectively suggest that ncpBVDV induces an
aberrant early T-cell response. Potgieter (17) has reviewed
possible mechanisms of immunosuppression, and, more spe-
cifically, production of an interleukin-1 (IL-1) inhibitor has
been suggested (14).
It is well established that the cytokine profile of T-cell re-
sponses is influenced by the cytokine environment during the
early stages of T-cell activation (1). Both IL-12 and IFN- itself
are known to promote differentiation to a Th1 phenotype (4).
There is also recent evidence from studies of human cells that
IFN-/ can promote Th1 responses (9). Hence, both the early
IFN-/ response and the IFN- produced 2 to 3 days after
infection with ncpBVDV are likely to have a role in determin-
FIG. 5. Kinetics of IFN- production (nanograms per milliliter) in the sera of gnotobiotic calves after intranasal challenge with 5  106 PFU
of ncpBVDV isolate 11249 (}). Individual samples were analyzed in duplicate, and the mean values were determined. Titers are expressed as the
means of values for six animals  SEM. Titers for the mock-infected animal are shown separately ().
FIG. 6. Profiles of TGF- in sera from gnotobiotic calves chal-
lenged intranasally with 5  106 PFU of ncpBVDV isolate 11249. Sera
were added to the TGF-1 assay either directly (A) or after activation
by acidification (B). Individual samples were analyzed in duplicate, and
the mean values were determined. Open bars show the mean values for
six gnotobiotic calves  SEM. Solid bars show the values for the
mock-infected animal.
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ing the cytokine profile of the subsequent T-cell response. A
previous study of T-cell responses of cattle that had recovered
from infection with BVDV, involving analysis of cytokine pro-
duction by purified T-cell subsets stimulated in vitro with virus-
infected cells, showed that CD4 T cells produced IL-4 bio-
logical activity but no IFN- but that CD8 T cells produced
IFN- but no IL-4 (18). It was suggested that a Th2 CD4-T-
cell response might interfere with protective Th1 responses to
other pathogens, such as bovine herpesvirus 1. However, no
evidence of a Th2-like response was found during the acute
phase of the infection in the present study. Furthermore, de-
tailed studies are required to determine how the cytokine pro-
files of virus-specific T-cell responses change during and fol-
lowing infection with ncpBVDV.
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